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INVESTIGATIONS INTO THE ETIOLOGY OF DERMATITIS
HERPETIFORMIS
II. THE EFFECTS OF SERUM FROM DERMATITIS HERPETITORMIS CASES AND OF
CERTAIN DRUGS ON THE VISCOSITY RED UCT[OY PROPERTY OF
HYALURONIDASE *
J. O'D. ALEXANDER, M.B., Css.B.
In a previous paper (1) it was shown that
serum from eases of dermatitis herpetiformis
(D.H.) had the property of accelerating the
spreading effect of hyaluronidase and that this
action was inhibited by treatment with Dap-
sone. The reduction of viscosity of solutions
of hyaluronic acid or its sodium or potassium
salts is another means of assessing hyaluroni-
dase activity. Normal human serum and many
other substances such as heparin, magnesium
and phosphate ions, ACTH, cortisone and
high concentrations of some antihistamines (2)
inhibit this action of hyaluronidase. The
effect of human serum can itself be inhibited
by some of these substances in weak concen-
tration; and certain substances, notably halo-
gen ions, have an accelerating effect on
hyaluronidase viscosity reduction at specific
concentrations. Glick and Gollan (3) and Grais
and Glick (4, 5) have shown that this hyaluron-
idase activity is markedly inhibited by serum
in certain acute infections such as poliomyelitis,
subacute bacterial endocarditis and primary
atypical pneumonia and in several skin dis-
orders such as pemphigus vulgaris, acute lupus
erythematosus and erythema multiforme. In all
these conditions inhibition was most marked at
the height of the infection and returned to
normal as the condition subsided. In the few
sera of D.H. which they tested the effects were
normal. Pyrexia did not increase the inhibitor
effect of normal serum.
The present tests were intended to verify
the D.H. sera findings and to ascertain whether
any drugs used in the treatment of this disease
influences hyaluronidase activity.
MATERIALS AND METHOD
Viscometer. A simple vertical U-tube Ostwald
viscometer (Fig. 1) was used. It had a capacity
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of 3.0 ml and a "falling time" for distilled water
of about 200 seconds. Tubes With similar falling
times should be used or results may vary con-
siderably.
Two stop-watches.
A thermostatically controlled water bath with
mechanical stirrer is essential. The viscometer is
charged by means of a Pasteur pipette sufficiently
long in the capillary portion to reach the lower
storage bulb and thus avoid air locks. The test solu-
tions are forced from the storage arm of the U tube
to the testing arm by positive pressure.
Test Solutions. Substrate-buffer mixture. (subse-
quently referred to as substrate): Four volumes of
0.5% commercial hyaluronic acid in distilled water
are mixed with one volume of molar sodium
citrate at pH 4.6 (this buffer contains approxi-
mately one volume of molar citric acid and 2
volumes of molar sodium hydroxide). The hyalu-
ronic acid was extracted from tumor tissue and
was obtained from Light and Co. Ltd. It gave
consistent readings with different batches. Ten mg
was found sufficient for 12 tests. Fresh substrate
must be made for each day's tests. Enryme solu-
tion: Commercial testicular hyaluronidase (fly-
alase-Benger) is dissolved in water so that 0.1
ml of the solution contains 2 units of enzyme.
Less than 2 units resulted in too slow a reaction
and 5 or 10 units was too fast except when testing
for strong inhibitory power (see Fig. 2).
Test Sera. Serum was obtained from normal
persons, from patients with netive and controlled
D.H. and from patients said to be in the febrile
stage of pneumonia. The latter scm were obtained
through the courtesy of Dr. R. G. Sommerville,
Virologist to Belvidere Hospital for Infectious
Diseases, Glasgow. All sera were diluted at the
time of testing so that 0.05 ml of solution con-
tained 0.01 ml of serum.
Therapeutic Agents. Dapsone, liquor arsenicalis
and other substances were suitably diluted to the
concentrations indicated in Table III. Sulfapyridine
could not be tested because it precipitated from
solution at pH 4.6
Method. The tests were carried out in the water
bath at 35.5°C. Between tests the viscometer was
cleaned by successive rinsing with warm water,
absolute alcohol and ether. The reaction mixtures
were prepared as follows:
a) Substrate 1.75 ml plus enzyme solution 02
ml plus distilled water 0.05 ml.
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knurled screws at the corners of the base
board
H. Thermometer
I. Basket containing reaction ingredients sub-
merged below the water level indicated by
the pencil line on the tank.
J. Ostwald viscometer. (It is in the wrong clamp
in the picture because otherwise it obscures
the other components. It is consequently not
quite vertical.)
b) As for a) but the enzyme first boiled for
30 minutes.
c) As for a) but 0.5 ml of test solution substi-
tuted for distilled water.
d) As for c) but the enzyme first boiled for 30
minutes.
The ingredients were kept at 35.5° C for 10
minutes before preparing these mixtures. Be-
cause the inhibitory effect of the test substances
might be delnyed the enzyme and test substance
were mixed 10 minutes before adding to the sub-
strate and testing.
Test. The reaction is timed by stop-watch from
the moment the mixture is completed. It is trans-
ferred at once to the viscometer and serial readings
of "falling time" are taken. In the case of mixture
a) the readings are taken until they are constant.
The falling time is plotted against reaction time
and the "half-viscosity" time determined. There-
after readings for the other mixtures are taken
until the half-viscosity level is reached.
Celculotions. The time, in seconds, taken to
reach half-viscosity level is designated R. F8 is
the value for F of the test substance and F0
the value for reaction mixture a). If the inhibitory
activity of the test substances is denoted by A
then
A = F. — F0
F0
The curves from which the value of F may be
ascertained are obtained from the test readings
taken at times designated to
1i
12 = I +
where I is the time on the first stop-watch at
which the reading is started and to is the reading
on the second stop-watch for each reading. Thus,
= 60 seconds and the falling time = 290 seconds,
then
29012 = 60 + = 205.
t is plotted as ordinate and t as abscissa.
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Fm. 1. Apparatus for determination of viscosity, arranged to show the various components
but not in the normal working manner as the latter is inconvenient for photography.
A. Electronic relay connected to
B. Heating element and controlled by
C. Toluene regulator set to 35.5° C.
D. Mechanical stirrer
E. Upright arm of stand, set exactly at right
angles to the base.
F. Horizontal arm exactly at right angles to the
upright arm
G. Two-dimensional spirit level adjusted by
1.
t
.t F
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Fic. 2. Graph showing the fall in viscosity of
substrate with different amounts of hyaluronidase.
The "half-viscosity" level lies midway between
the falling time of the inactive reaction mixture
and that of the completed reaction. The point at
which the various curves cross this line is desig-
nated the relative half-viscosity time (R). It
can be seen from the graph that with 5 or 10
units per ml. the value for R is very small and
consequently any small changes, would be very
difficult to detect and measure. With 1 unit per ml
the time is too long and for this reason the amount
of 2 units per ml was chosen as the most suitable
for the tests.
0 = 1 unit of hyaluronidase per ml; + = 2
units of hyaluronidase per ml; X = 5 units of
hyaluronidase per ml; = 10 units of hyalu-
ronidase per ml.
FIG. 3. Viscosity diagram for a serum from a
case of dermatitis herpetiformis. The serum has a
slightly inhibiting influence on the reaction. The
value for A is +0.26.
X = Substrate + enzyme + water; 0 Sub-
strate + enzyme + serum.
r>
Falling ti,ne of co,npl.fe ronation.
5 II 15 20 25 35 40
RE.TION TIME (mins.)
Fic. 4. Viscosity diagram for Dapsone. At very
weak concentration it has a slight accelerating
effect but at a concentration of 0.001 mg per test
there was a strong inhibitory effect. At higher con-
centrations the inhibitory action was complete.
X = Substrate + enzyme + water; • = Sub-
strate + enzyme + Dapsone, 0.0001 mg; Q = Sub-
strate + enzyme + Dapsone, 0.001 mg.
TABLE I
Results of viscosity tests for cases of
dermatitis herpetiformis
The figures are for values of A (see text). There
is no statistical difference between the two
groups.
Mean +0.61 +0.42
RESULTS
The results of the viscosity reduction tests
have been expressed as values of the factor
A. Examples of the different reaction curves
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Case Active state
H. C.
I. F.
F. MeG.
T. A.
D. M.
R. H.
J. R.
F. B.
F. B.
J. S.
A. H.
—0.50
+0.26
+2.04
+0.33
+0.41
+0.70
—0.03
+0.09
+1.30
+0.96
+1.19
Controlled state
+2.25
+0.39
—0.26
+0.43
+0.45
+0.10
—0.04
+0.02
35 35 40
REACTION TIME (mins.)
are given in figures 2 to 4 and the values for
A in Tables I to IV. The results were analyzed
statistically using "Student's" 't' test. Com-
paring the figures for active and controlled
dermatitis herpetiformis in Table I with those
for normal sara in Table I, active serum was
less inhibitory than normal serum but just not
significantly so at P = 0.05. After treatment,
however, the dermatitis herpetiformis serum
76 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Test Serum
Febeile Sera Value foe A
Test Serum
Normal Sera Value foe A
1
2
3
4
5
6
+0.47
+0.34
+1.30
—0.17
+0.25
—0.03
a
b
C
d
e
f
+1.51
+2.72
+1.02
+0.82
+0.74
+1.20
Mean +0.36 +1.335
TABLE III
Values of A with varying amounts of drugs tested
The amounts indicated were the actual quan-
tities of drug present in 2 ml of reaction mixture.
Amouot of
Inhibitor io the
Test Mixture
was significantly less inhibitory thau normal
serum (P lay between 0.05 and 0.02). A pos-
sible explanation of tbis anomaly is given be-
low.
nlscussloN
The determination of viscosity of biological
fluids is set about by many complicating
factors among which arc PH, ionic concentra-
tion of salts, optimal temperature, the choice
of substrate and even of viscometer. The
presence of small amounts of sodium chloride
may make a very great difference to the re-
sults. In low concentration it has an accelerat-
ing effect on the reaction (6). For this reason
the substrate in these tests has been dissolved
in water rather than in weak solution of
sodium chloride as used by Madinaveitia and
Quibdll (7). The pH of 4.6 has been shown to
be optimal for hyalurnnidase activity (8.6), al-
though there is still considerable activity for a
wide margin on either side of this figure. The
choice of substrate is important. The commer-
cially prepared sodium salt of hyaluronic acid
described here gave easily reproducible results.
The results detailed reveal one or two inter-
esting findings. As far as the various sera are
concerned there is little comment to make. The
evidence confirms the findings of Glick at al.
concerning serum of D.H. The sera of the
TABLE II
Results of viscosity tests with febrile
pneumonia sera and normal sera
The figures are for values of A (see text). The
febrile sara were significantly less inhibitory of
hyalurouidase activity than normal sera.
Inhibitor
Daps one
Potassium iodide
As2Os as liquor ar-
senicalis
Hydrocortisone
acetate
Phenergan
Heparin
in- TABLE IV
Values for A when the test substances were tested
against 10 units of hyaluronidase
per ml of substrate mixture
mg
1.0
0.01
0.001
0.0001
0.1
0.001
0.0001
0.001
0.0001
0.01
0.01
12.5 units
Value of A
Complete
hibitinn
+ 1.45
+0.45
—0.12
Complete
hibition
+0.96
+0.28
+0.72
+0.68
+ 1.57
+0.99
Complete
hibition
Test Substances
in-
Febrile serum
1
2
6
Normal serum
a
b
Active serum
H. C.
J. 17.
in- j
Dapsnne, 0.001 mg
Potassium iodide, 0.001
mg
Heparin, 12.5 units
Values of A
+0.22
—0.15
—0.20
+0.08
+0.08
—0.20
—0.15
+0.22
Complete inhibition
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patients with pneumonia did not give the re-
suits anticipated but this may be because the
exact time during the disease at which the
sera were taken was not accurately specified.
Heparin was confirmed as a potent inhibitor
of hyaluronidase activity. Dapsone was also
shown to be powerfully inhibitory, even at
weak concentration. At a concentration of
0.0001 mg per test, however, there was slight
accelerating activity (Fig. 5). A clinical dose of
100 mg Dapsone completely absorbed into a
blood stream with a volume of 5 liters would
result in a plasma concentration approximately
equivalent to 0.07 mg in 2 ml (the volume of
the reaction mixture). At approximately 15%
of this strength (0.01 mg) Dapsone was
strongly inhibitory. On the other hand 0.01
ml of such serum, which is the amount of
serum used in the test, would contain about
0.00035 mg. This is the maximum probable
amount in any of the reaction mixtures used
in these tests, many of which would contain
only 0.0001 mg. This has a slight accelerating
effect on viscosity reduction and might explain
why serum from Dapsone-treated patients has
a less inhibitory effect than that from untreated
patients.
Of the other substances tested the most in-
teresting was potassium iodide a well known
cause of acute exacerbation of D.H. when
administered orally. It had an inhibitory action
on viscosity reduction which varied with con-
centration. These apparent contradictions may
possibly be accounted for by the ionic con-
centration of the potassium solutions used.
MeClean and Hale (6) have shown that at
very weak molar concentration chloride ions
have an accelerating effect on viscosity reduc-
tion but as the concentration increases this
changes to an inhibition. Madinaveitia and
MeClean (10) showed that, at concentrations
which cause inhibition, iodide ions have a
greater effect than chloride ions. This inhibit-
ing property also applies to the spreading
effects of hyaluronidase in skin. The aggravat-
ing influence of iodides in D.H. might be
explained on the grounds that only low serum
concentrations are achieved by the dosage used.
Bearing in mind that there are a very large
numher of complex processes involved, it does,
however, seem that the serum of D.H. has an
inhibitory effect on viscosity reduction by
hyaluronidase of solutions of hyaluronic acid.
The inhibitory effect is rather less than that of
normal serum but does not tally exactly with
the findings in skin spreading (1). Dapsone,
which is an excellent therapeutic weapon in
D.H., is also a powerful hyaluronidase inhibitor.
Added to the previous finding that Dapsone
inhibits the accelerating effect of DII. serum
on the spreading property of hyaluronidase,
this may have some significance on the mecha-
nism of action of Dapsone in D.H.
SUMMARY
Examination by viseometry had shown that
serum from dermatitis herpetiformis has an
inhibitory effect slightly less than that of nor-
mal serum on the viscosity-reducing property
of hyaluronidase. Dapsone, used for the treat-
ment of dermatitis herpetiformis, is strongly
inhibitory at levels likely to be achieved by
therapeutic doses.
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